Targeted Drug Delivery Technologies Potentiate the Overall Therapeutic Efficacy of an Indole Derivative in a Mouse Cystic Fibrosis Setting
Matteo Puccetti(University of Perugia), Stefano Giovagnoli(University of Perugia), Maurizio Ricci(University of Perugia), Giorgia Renga(University of Perugia), Claudio Costantini(University of Perugia), Claudia Stincardini(University of Perugia), Marina Maria Bellet(University of Perugia), Fiorella D’Onofrio(University of Perugia), Luigina Romani(University of Perugia), Ilaria Santarelli(University of Perugia), Andréa Bartoli(University of Perugia), Marilena Pariano(University of Perugia)
Cited by 24
Related Papers
Genetic PTX3 Deficiency and Aspergillosis in Stem-Cell Transplantation
|New England Journal of Medicine|2014|301
TLRs Govern Neutrophil Activity in Aspergillosis
|The Journal of Immunology|2004|238
IL-1 receptor antagonist ameliorates inflammasome-dependent inflammation in murine and human cystic fibrosis
|Nature Communications|2016|232
Biologics, theranostics, and personalized medicine in drug delivery systems
|Pharmacological Research|2024|185
Neutrophil production of IL-12 and IL-10 in candidiasis and efficacy of IL-12 therapy in neutropenic mice
|The Journal of Immunology|1997|175